Trapidil

CAS No. 15421-84-8

Trapidil( Trapidil | AR 12008 | AR-12008 | AR12008 )

Catalog No. M12182 CAS No. 15421-84-8

Trapidil is a vasodilator, is an antiplatelet drug with specific platelet-derived growth factor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 29 In Stock
25MG 53 In Stock
50MG 86 In Stock
100MG 141 In Stock
200MG 207 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Trapidil
  • Note
    Research use only, not for human use.
  • Brief Description
    Trapidil is a vasodilator, is an antiplatelet drug with specific platelet-derived growth factor.
  • Description
    Trapidil is a vasodilator, is an antiplatelet drug with specific platelet-derived growth factor.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Trapidil | AR 12008 | AR-12008 | AR12008
  • Pathway
    Angiogenesis
  • Target
    PDE
  • Recptor
    PDE| PDGFR
  • Research Area
    Cardiovascular Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    15421-84-8
  • Formula Weight
    205.26
  • Molecular Formula
    C10H15N5
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 10 mM
  • SMILES
    CC1=NC2=NC=NN2C(N(CC)CC)=C1
  • Chemical Name
    (1,2,4)Triazolo(1,5-a)pyrimidin-7-amine, N,N-diethyl-5-methyl-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Kim SD, et al. Biochem Pharmacol. 2013 Sep 15;86(6):782-90.
molnova catalog
related products
  • Avanafil

    A potent and highly selective PDE5 inhibitor (IC50=5.2 nM) for erectile dysfunction.

  • ONO-8430506

    ONO-8430506 is an orally available, potent autotaxin (ATX)/ENPP2 inhibitor (IC90: 100 nM) that inhibits ATX activity in mouse plasma.

  • Triflusal

    Triflusal is a platelet aggregation inhibitor that was discovered and developed in the Uriach Laboratories, and commercialised in Spain since 1981.